SURG(SURG)
SURG
NASDAQ
$0.16—
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $65M | $80M |
| Low | $65M | $80M |
| High | $65M | $80M |
| EBITDA Avg | $-12M | $3M |
| Low | $-12M | $3M |
| High | $-12M | $3M |
| EBIT Avg | $-13M | $2M |
| Low | $-13M | $2M |
| High | $-13M | $2M |
| Net Income Avg | $-14M | $1M |
| Low | $-14M | $1M |
| High | $-14M | $1M |
| EPS Avg | $-0.70 | $0.05 |
| Low | $-0.70 | $0.05 |
| High | $-0.70 | $0.05 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $19M | $17M | $19M | $17M | $23M | $21M |
| Low | $19M | $17M | $19M | $17M | $23M | $21M |
| High | $19M | $17M | $19M | $17M | $23M | $21M |
| EBITDA Avg | $-857,447 | $689,522 | $941,300 | $415,341 | $3M | $2M |
| Low | $-857,447 | $689,522 | $941,300 | $415,341 | $3M | $2M |
| High | $-857,447 | $689,522 | $941,300 | $415,341 | $3M | $2M |
| EBIT Avg | $-1M | $472,996 | $732,213 | $213,779 | $3M | $2M |
| Low | $-1M | $472,996 | $732,213 | $213,779 | $3M | $2M |
| High | $-1M | $472,996 | $732,213 | $213,779 | $3M | $2M |
| Net Income Avg | $-2M | $-518,433 | $-259,216 | $-777,650 | $2M | $777,650 |
| Low | $-2M | $-518,433 | $-259,216 | $-777,650 | $2M | $777,650 |
| High | $-2M | $-518,433 | $-259,216 | $-777,650 | $2M | $777,650 |
| EPS Avg | $-0.08 | $-0.02 | $-0.01 | $-0.03 | $0.06 | $0.03 |
| Low | $-0.08 | $-0.02 | $-0.01 | $-0.03 | $0.06 | $0.03 |
| High | $-0.08 | $-0.02 | $-0.01 | $-0.03 | $0.06 | $0.03 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |